Skip to main content
Caplight Logo









bYoRNA

bYoRNA

Private
BordeauxHealthcare & Life Scienceshttps://www.byorna.bio/

Last Round

Series A

Mar 25, 2026

Total Funding Raised

$1.76M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

bYoRNA is a biotechnology company that develops a yeast-based fermentation platform for the production of therapeutic messenger RNA (mRNA).

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Biotech Equipment

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Non-AI

Keywords

mRNA bioproductionyeast fermentationin vitro transcriptionIVTbiomanufacturingsynthetic biologymRNA therapeuticsgene therapycancer immunotherapybiotech platformcontract manufacturingCDMOmRNA manufacturingbiotech services

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

bYoRNA Comparables

Compare bYoRNA with similar companies based on industry and business-model similarity.

bYoRNA comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Sensible Biotechnologies
81%
Cisterna Biologics
77%
RiboPro
75%

bYoRNA Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMar 25, 2026
Pre SeedSep 8, 2025
AcceleratorNov 1, 2022

bYoRNA Investors

Notable investors and investment history

bYoRNA investors
InvestorRounds
AntlerAccelerator
IRDI Soridec GestionPre Seed
IQ-EQPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 25, 2026

    Completed a Series A funding round.

  • Mar 4, 2026

    Monthly visitors grew 670% MoM, from 137 to 1.1K.

bYoRNA Filings

Explore SEC and related filing metadata, where available.

bYoRNA filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about bYoRNA's valuation, stock price, and market status.

Is bYoRNA a public or private company?

bYoRNA is a private company.

What is the current stock price of bYoRNA?

bYoRNA is a private company with no public stock price. Caplight tracks bYoRNA's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is bYoRNA worth (valuation)?

Valuation information for bYoRNA is not publicly available.

Can I buy bYoRNA stock?

bYoRNA shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was bYoRNA's last funding round?

bYoRNA's most recent funding round was Series A on March 25, 2026.

Who are the main investors in bYoRNA?

Key investors in bYoRNA include IQ-EQ.

Will bYoRNA IPO soon?

No public IPO plans have been announced for bYoRNA.

How can I track bYoRNA secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor bYoRNA's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBordeaux
Employee Range15
Year Founded2022
Last FundingMar 25, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?